Marathon Trading Investment Management LLC Catalent, Inc. Transaction History

Marathon Trading Investment Management LLC

$201 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 May 24, 2023	BUY	$41.39 - $81.0 $912,690 - $1.79 Million	22,051 New	22,051 $992,000
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $912,690 - $1.79 Million	22,051 New	22,051 $993,000

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

Vanguard Group Inc Valley Forge, PA

20.2M
Shares

$1.23 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

15.4M
Shares

$936 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$454 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$390 Million
0.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$276 Million
0.14% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account